ArticleBMJ open2024

Two-fractionated stereotactic magnetic resonance-guided adaptive radiation therapy for patients with prostate cancer (SMART PRO trial): protocol for a confirmatory clinical trial.

Sadamoto Zenda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.